26th November 2018
Radisson Blu Plaza Hotel Ljubljana (Slovenian language)
PACIENT SUPPORT PROGRAM – WHAT IS ALLOWED IN THE EU AND WHAT IS NOT?
The importance of patient support programs (PSPs), which aim at better adherence and thus successful treatment, is increasingly becoming a regulatory focus due to conflict of:
- unquestionable benefits for patients and the quality of health care, and
- unclear European legislation that allows different interpretations and opens the space of ingenuity in overcoming boundaries that separate us from the advertising of prescription drugs to the general public or patients.
Therefore, a number of court cases and attempts to voluntarily harmonize the positions of the EU Member States on what can and what should not be done in this area, are a response to this situation. Patients and health professionals often need help, and the industry needs a legally foreseeable environment for its operation. It is therefore important to answer the question of what can and what should not be done in relation to the preparation of patient support programs.
Click HERE for more info on educational conference.
Click HERE to apply for educational conference.